Stefan Peukert

This inventor holds 31 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Novartis Ag, Aventis Pharma Deutschland, Gmbh, Sanofi-A Ventis Deutschland Gmbh. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Peukert. Retrieved from https://idiyas.com/inventor/stefan-peukert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 9)

% Patents Active = 64.5

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 12)

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 166(Granted Patents)

Location History:

Franfurt, DE (2004)
Frankfurt-am-Main, DE (2003 - 2012)
Cambridge, MA (US) (2013 - 2018)
Arlington, MA (US) (2010 - 2024)

Company Filing History:

Aventis Pharma Deutschland, Gmbh

patents

5 out of 1,855

Sanofi-A Ventis Deutschland Gmbh

Aventis Pharmaceuticals Inc.

patents

6. 1 out of 47

Bausch + Lomb Ireland Limited

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

Naphthyridinone Derivatives

Selective Estrogen Receptor Degraders

Cyclobutyl Derivatives

Pyridone Derivatives

Isoquinoline Derivatives

Anthranilamides

Hedgehog Signaling Pathway

Pyridazinyl Derivatives

Poly(ADP-Ribose) Polymerase Inhibitors

Bisaryl Compounds

Pharmaceutical Preparations

Medicaments

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435040 - 1,3-substituted cyclobutyl derivatives and uses thereof (2025-10-07),

2. 12084442 - Naphthyridinone derivatives for the treatment of a disease or disorder (2024-09-10),

3. 11845730 - 1,3-substituted cyclobutyl derivatives and uses thereof (2023-12-19),

4. 11530213 - Naphthyridinone derivatives and their use in the treatment of arrhythmia (2022-12-20),

5. 10844055 - Naphthyridinone derivatives and their use in the treatment of arrhythmia (2020-11-24),

6. 10266531 - Naphthyridinone derivatives and their use in the treatment of arrhythmia (2019-04-23),

7. 10058534 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders (2018-08-28),

8. 9931317 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders (2018-04-03),

9. 9561211 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders (2017-02-07),

10. 9546138 - Pyridone derivatives and uses thereof in the treatment of tuberculosis (2017-01-17),

11. 9409871 - Pyridazinyl derivatives as SMO inhibitors (2016-08-09),

12. 9321746 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders (2016-04-26),

13. 8877801 - Compounds and compositions as selective estrogen receptor degraders (2014-11-04),

14. 8722671 - Isoquinoline derivatives (2014-05-13),

15. 8710228 - Cycloalkylamine substituted isoquinoline derivatives (2014-04-29),

Title: The Innovative Journey of Stefan Peukert

Introduction: Stefan Peukert is a renowned inventor based in Arlington, MA, known for his groundbreaking contributions to various industries.

Latest Patents: Stefan Peukert holds several patents in the fields of technology and healthcare, showcasing his continuous innovation and dedication to improving people's lives.

Career Highlights: With a career spanning over two decades, Stefan Peukert has worked on numerous projects that have revolutionized the way we interact with technology. His keen eye for detail and passion for innovation have led to the development of cutting-edge solutions.

Collaborations: Throughout his career, Stefan Peukert has collaborated with leading companies, research institutions, and universities to bring his ideas to life. His ability to work in diverse teams and leverage collective expertise has been instrumental in his success.

Conclusion: Stefan Peukert's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true visionary in the world of inventors.

Profile summary based on public USPTO records.